More on CTNM

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (5.7 Score)

Upcoming Events

- Earnings (11/11/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Contineum Therapeutics (NQ:CTNM)
Delayed: 8.14 --0 (-0%)
Prev. Close $8.14  
Open$8.14 
52 Wk High$ 
52 Wk Low$ 
Day High$8.14 
Day Low$8.14 
P/E N/A  
EPS$ 
Volume9 

Friends, Peers and Foes (?): BMY (more...)

Oct 22, 2026 04:16 PM Form SCHEDULE 13G Contineum Therapeutics, Filed by: Trails Edge Capital Partners, LP
Oct 14, 2026 07:07 AM Contineum Therapeutics (CTNM) PT Raised to $30 at Jones Trading
Oct 13, 2026 08:43 AM Baird Downgrades Contineum Therapeutics (CTNM) to Neutral
Oct 12, 2026 07:27 AM Contineum Therapeutics stock surges on Bristol Myers trial win
Oct 1, 2026 04:21 PM Form 144 Contineum Therapeutics, Filed by: Lorrain Daniel S.
Sep 30, 2026 09:58 AM Stifel Reiterates Buy Rating on Contineum Therapeutics (CTNM)
Sep 29, 2026 04:45 PM Wells Fargo Sees Liver Safety Risk In Bristol Admilparant Trial - Bloomberg
Sep 29, 2026 03:52 PM Contineum Therapeutics (CTNM) Halted on Volatility, Down 15%
Sep 28, 2026 08:25 AM Contineum Therapeutics (CTNM) PT Lowered to $17 at Morgan Stanley
Sep 24, 2026 05:00 AM Goldman Sachs Assumes Contineum Therapeutics (CTNM) at Early-Stage Biotech
View All Articles

Entities mentioned with CTNM

View All Entities